Bio-Rad Laboratories ROA 2010-2023 | BIO
Current and historical return on assets (ROA) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Bio-Rad Laboratories ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $-0.64B | $12.30B | -5.11% |
| 2023-09-30 | $-0.16B | $11.90B | -1.25% |
| 2023-06-30 | $-0.43B | $11.98B | -3.34% |
| 2023-03-31 | $-0.19B | $13.67B | -1.47% |
| 2022-12-31 | $-3.63B | $13.50B | -27.57% |
| 2022-09-30 | $-6.02B | $12.06B | -42.31% |
| 2022-06-30 | $-1.93B | $12.68B | -11.91% |
| 2022-03-31 | $-0.09B | $14.37B | -0.54% |
| 2021-12-31 | $4.25B | $17.80B | 25.47% |
| 2021-09-30 | $6.67B | $19.95B | 43.02% |
| 2021-06-30 | $4.05B | $15.12B | 30.00% |
| 2021-03-31 | $4.11B | $13.93B | 33.49% |
| 2020-12-31 | $3.81B | $12.97B | 34.85% |
| 2020-09-30 | $3.52B | $12.02B | 36.28% |
| 2020-06-30 | $1.95B | $10.10B | 22.92% |
| 2020-03-31 | $1.58B | $8.68B | 20.04% |
| 2019-12-31 | $1.76B | $8.01B | 23.68% |
| 2019-09-30 | $0.38B | $7.18B | 5.51% |
| 2019-06-30 | $0.90B | $7.65B | 13.47% |
| 2019-03-31 | $0.57B | $6.86B | 8.96% |
| 2018-12-31 | $0.37B | $5.61B | 5.86% |
| 2018-09-30 | $1.28B | $6.72B | 21.65% |
| 2018-06-30 | $1.03B | $6.39B | 19.56% |
| 2018-03-31 | $0.77B | $6.22B | 16.30% |
| 2017-12-31 | $0.12B | $4.27B | 2.95% |
| 2017-09-30 | $0.02B | $4.19B | 0.40% |
| 2017-06-30 | $0.01B | $4.14B | 0.30% |
| 2017-03-31 | $0.03B | $3.95B | 0.64% |
| 2016-12-31 | $0.03B | $3.85B | 0.65% |
| 2016-09-30 | $0.09B | $4.02B | 2.45% |
| 2016-06-30 | $0.09B | $3.88B | 2.48% |
| 2016-03-31 | $0.10B | $3.75B | 2.81% |
| 2015-12-31 | $0.11B | $3.71B | 3.06% |
| 2015-09-30 | $0.10B | $3.67B | 2.94% |
| 2015-06-30 | $0.10B | $3.53B | 2.86% |
| 2015-03-31 | $0.10B | $3.33B | 2.99% |
| 2014-12-31 | $0.09B | $3.34B | 2.64% |
| 2014-09-30 | $0.08B | $3.39B | 2.37% |
| 2014-06-30 | $0.06B | $3.47B | 1.83% |
| 2014-03-31 | $0.07B | $3.44B | 1.91% |
| 2013-12-31 | $0.08B | $3.39B | 2.29% |
| 2013-09-30 | $0.09B | $3.28B | 2.66% |
| 2013-06-30 | $0.14B | $3.48B | 4.12% |
| 2013-03-31 | $0.15B | $3.46B | 4.61% |
| 2012-12-31 | $0.17B | $3.44B | 5.04% |
| 2012-09-30 | $0.18B | $3.30B | 5.71% |
| 2012-06-30 | $0.19B | $3.17B | 5.96% |
| 2012-03-31 | $0.18B | $3.19B | 5.76% |
| 2011-12-31 | $0.18B | $3.10B | 5.96% |
| 2011-09-30 | $0.19B | $2.97B | 6.24% |
| 2011-06-30 | $0.19B | $3.04B | 6.36% |
| 2011-03-31 | $0.18B | $2.91B | 6.58% |
| 2010-12-31 | $0.19B | $3.06B | 6.88% |
| 2010-09-30 | $0.16B | $2.68B | 6.06% |
| 2010-06-30 | $0.15B | $2.53B | 5.95% |
| 2010-03-31 | $0.15B | $2.55B | 6.06% |
| 2009-12-31 | $0.15B | $2.54B | 6.23% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.934B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Baxter (BAX) | United States | $20.785B | 15.16 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |